526 related articles for article (PubMed ID: 21504142)
1. Drug to genome to drug: discovery of new antiplasmodial compounds.
Beghyn TB; Charton J; Leroux F; Laconde G; Bourin A; Cos P; Maes L; Deprez B
J Med Chem; 2011 May; 54(9):3222-40. PubMed ID: 21504142
[TBL] [Abstract][Full Text] [Related]
2. Drug-to-genome-to-drug, step 2: reversing selectivity in a series of antiplasmodial compounds.
Beghyn TB; Charton J; Leroux F; Henninot A; Reboule I; Cos P; Maes L; Deprez B
J Med Chem; 2012 Feb; 55(3):1274-86. PubMed ID: 22204607
[TBL] [Abstract][Full Text] [Related]
3. In vitro efficiency of new acridyl derivatives against Plasmodium falciparum.
Guetzoyan L; Ramiandrasoa F; Dorizon H; Desprez C; Bridoux A; Rogier C; Pradines B; Perrée-Fauvet M
Bioorg Med Chem; 2007 May; 15(9):3278-89. PubMed ID: 17339112
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 2-[3-(7-Chloro-quinolin-4-ylamino)-alkyl]-1-(substituted phenyl)-2,3,4,9-tetrahydro-1H-beta-carbolines as a new class of antimalarial agents.
Gupta L; Srivastava K; Singh S; Puri SK; Chauhan PM
Bioorg Med Chem Lett; 2008 Jun; 18(11):3306-9. PubMed ID: 18442907
[TBL] [Abstract][Full Text] [Related]
5. Application of multicomponent reactions to antimalarial drug discovery. Part 3: discovery of aminoxazole 4-aminoquinolines with potent antiplasmodial activity in vitro.
Musonda CC; Little S; Yardley V; Chibale K
Bioorg Med Chem Lett; 2007 Sep; 17(17):4733-6. PubMed ID: 17644333
[TBL] [Abstract][Full Text] [Related]
6. Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules.
Sung BJ; Hwang KY; Jeon YH; Lee JI; Heo YS; Kim JH; Moon J; Yoon JM; Hyun YL; Kim E; Eum SJ; Park SY; Lee JO; Lee TG; Ro S; Cho JM
Nature; 2003 Sep; 425(6953):98-102. PubMed ID: 12955149
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and structure-activity relationship of functionalized tetrahydro-β-carboline derivatives as novel PDE5 inhibitors.
Ahmed NS; Gary BD; Tinsley HN; Piazza GA; Laufer S; Abadi AH
Arch Pharm (Weinheim); 2011 Mar; 344(3):149-57. PubMed ID: 21384413
[TBL] [Abstract][Full Text] [Related]
8. Exploring the PDE5 H-pocket by ensemble docking and structure-based design and synthesis of novel β-carboline derivatives.
Ahmed NS; Ali AH; El-Nashar SM; Gary BD; Fajardo AM; Tinsley HN; Piazza GA; Negri M; Abadi AH
Eur J Med Chem; 2012 Nov; 57():329-43. PubMed ID: 23117589
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains.
Gemma S; Kukreja G; Fattorusso C; Persico M; Romano MP; Altarelli M; Savini L; Campiani G; Fattorusso E; Basilico N; Taramelli D; Yardley V; Butini S
Bioorg Med Chem Lett; 2006 Oct; 16(20):5384-8. PubMed ID: 16890433
[TBL] [Abstract][Full Text] [Related]
10. Antimalarial and antiplasmodial activities of norneolignans. Syntheses and SAR.
Skytte DM; Nielsen SF; Chen M; Zhai L; Olsen CE; Christensen SB
J Med Chem; 2006 Jan; 49(1):436-40. PubMed ID: 16392829
[TBL] [Abstract][Full Text] [Related]
11. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation.
Blount MA; Beasley A; Zoraghi R; Sekhar KR; Bessay EP; Francis SH; Corbin JD
Mol Pharmacol; 2004 Jul; 66(1):144-52. PubMed ID: 15213306
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of 1-amino-6-halo-β-carbolines as antimalarial and antiprion agents.
Thompson MJ; Louth JC; Little SM; Jackson MP; Boursereau Y; Chen B; Coldham I
ChemMedChem; 2012 Apr; 7(4):578-86. PubMed ID: 22275299
[TBL] [Abstract][Full Text] [Related]
13. Design of novel β-carboline derivatives with pendant 5-bromothienyl and their evaluation as phosphodiesterase-5 inhibitors.
El-Gamil DS; Ahmed NS; Gary BD; Piazza GA; Engel M; Hartmann RW; Abadi AH
Arch Pharm (Weinheim); 2013 Jan; 346(1):23-33. PubMed ID: 23307609
[TBL] [Abstract][Full Text] [Related]
14. Cyclic nucleotide-specific phosphodiesterases of Plasmodium falciparum: PfPDEalpha, a non-essential cGMP-specific PDE that is an integral membrane protein.
Wentzinger L; Bopp S; Tenor H; Klar J; Brun R; Beck HP; Seebeck T
Int J Parasitol; 2008 Dec; 38(14):1625-37. PubMed ID: 18590734
[TBL] [Abstract][Full Text] [Related]
15. An update on cyclic nucleotide phosphodiesterase (PDE) inhibitors: phosphodiesterases and drug selectivity.
Gupta R; Kumar G; Kumar RS
Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):101-18. PubMed ID: 15834463
[TBL] [Abstract][Full Text] [Related]
16. A FYVE-containing unusual cyclic nucleotide phosphodiesterase from Trypanosoma cruzi.
Kunz S; Oberholzer M; Seebeck T
FEBS J; 2005 Dec; 272(24):6412-22. PubMed ID: 16336277
[TBL] [Abstract][Full Text] [Related]
17. Antiplasmodial activities of 4-aminoquinoline-statine compounds.
Vaiana N; Marzahn M; Parapini S; Liu P; Dell'Agli M; Pancotti A; Sangiovanni E; Basilico N; Bosisio E; Dunn BM; Taramelli D; Romeo S
Bioorg Med Chem Lett; 2012 Sep; 22(18):5915-8. PubMed ID: 22884991
[TBL] [Abstract][Full Text] [Related]
18. Pharmacophore based discovery of potential antimalarial agent targeting haem detoxification pathway.
Acharya BN; Saraswat D; Kaushik MP
Eur J Med Chem; 2008 Dec; 43(12):2840-52. PubMed ID: 18395298
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Plasmodium falciparum pH regulation by small molecule indole derivatives results in rapid parasite death.
van Schalkwyk DA; Chan XW; Misiano P; Gagliardi S; Farina C; Saliba KJ
Biochem Pharmacol; 2010 May; 79(9):1291-9. PubMed ID: 20067768
[TBL] [Abstract][Full Text] [Related]
20. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
